Current Issue February 2012, Vol. 9, No. 2
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be life-saving for some patients, the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRS) have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies.
Read the full article
-
Ablation of Ventricular Arrhythmias Arising Near the Anterior Epicardial Veins from the Left Sinus of Valsalva Region: ECG Features, Anatomic Distance And Outcome03 February 2012
-
Epicardial Ganglionated Plexus Stimulation Decreases Post-Operative Inflammatory Response in Humans03 February 2012
-
Impairment of trafficking by downregulation of an anchor protein: novel insights into additional mechanisms responsible for heart failure02 February 2012
-
High Degree Right Bundle Branch Block Obscuring the Diagnosis of Brugada Electrocardiographic Pattern02 February 2012
-
R-on-T and Cardiac Arrest from Dual-Chamber Pacing without an Atrial Lead01 February 2012








